CERVIRAY Trademark

Trademark Overview


On Monday, August 2, 2021, a trademark application was filed for CERVIRAY with the United States Patent and Trademark Office. The USPTO has given the CERVIRAY trademark a serial number of 79319631. The federal status of this trademark filing is REGISTERED as of Tuesday, November 7, 2023. This trademark is owned by AIDOT Inc.. The CERVIRAY trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Cervical cancer screening services; Cancer screening services, namely, RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; bowel cancer screening services; breast cancer screening services; health care services for treating cancer

Medical apparatus and instruments in the fields of clinical diagnosis, namely, medical diagnostic imaging apparatus delivering information to medical diagnostic users, medical diagnostic imaging apparatus achieving images from medical diagnostic uses, medical imaging apparatus displaying diagnostic information, electromagnetic medical diagnostic imaging apparatus incorporating recorded software for diagnostic uses, namely, for detecting the location of inflammation, abnormal and metamorphosed tissues, cells and cancer, detecting locations for biopsy, analysis of severity or possibility of inflammation, abnormal or metamorphosed tissues, cells and cancer, and estimating inflammation, abnormal tissues, cells and cancer; flow cytometers for medical diagnostic uses, sample preparation devices for medical diagnostic uses, electromagnetic medical diagnostic imaging apparatus; diagnostic, examination, and monitoring equipment, namely, visual inspection apparatus in the nature of endoscopy cam...
cerviray

General Information


Serial Number79319631
Word MarkCERVIRAY
Filing DateMonday, August 2, 2021
Status700 - REGISTERED
Status DateTuesday, November 7, 2023
Registration Number7209294
Registration DateTuesday, November 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Goods and ServicesCervical cancer screening services; Cancer screening services, namely, RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; bowel cancer screening services; breast cancer screening services; health care services for treating cancer
Goods and ServicesMedical apparatus and instruments in the fields of clinical diagnosis, namely, medical diagnostic imaging apparatus delivering information to medical diagnostic users, medical diagnostic imaging apparatus achieving images from medical diagnostic uses, medical imaging apparatus displaying diagnostic information, electromagnetic medical diagnostic imaging apparatus incorporating recorded software for diagnostic uses, namely, for detecting the location of inflammation, abnormal and metamorphosed tissues, cells and cancer, detecting locations for biopsy, analysis of severity or possibility of inflammation, abnormal or metamorphosed tissues, cells and cancer, and estimating inflammation, abnormal tissues, cells and cancer; flow cytometers for medical diagnostic uses, sample preparation devices for medical diagnostic uses, electromagnetic medical diagnostic imaging apparatus; diagnostic, examination, and monitoring equipment, namely, visual inspection apparatus in the nature of endoscopy cameras for medical diagnostic purposes, and visualization imaging apparatus for medical purposes, medical imaging achievement apparatus and medical imaging capture apparatus; visual screening apparatus in the nature of endoscopy cameras for medical diagnostic purposes, and visualization imaging apparatus for medical purposes, medical imaging achievement apparatus and medical imaging capture apparatus; diagnostic apparatus achieving images in the nature of endoscopy cameras for medical diagnostic purposes, and visualization imaging apparatus for medical purposes, medical imaging achievement apparatus and medical imaging capture apparatus; medical apparatus for diagnostic uses using lighting in the nature of diagnostic pen lights for medical purposes, ultrasound diagnostic apparatus, X-ray diagnostic apparatus, diagnostic apparatus for the detection of cancer; testing instruments for medical diagnostic purposes, namely, testing apparatus delivering information supporting cytology in the nature of medical diagnostic apparatus for testing metamorphosed cells, abnormal tissues, cancer cells, inflammation; medical diagnostic apparatus using acetic acid for testing metamorphosed cells, abnormal tissues, cancer cells, inflammation; visual testing apparatus in the nature of eye testing apparatus, blood testing apparatus, medical diagnostic apparatus for testing for viruses, medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA and RNA; tools for medical diagnostics, namely, medical diagnostic apparatus for testing for viruses, medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA and RNA samples; sensor apparatus for medical use in diagnosis, namely, image capturing patient monitoring sensors for medical diagnostic uses, sensor apparatus in the nature of patient monitoring sensor displaying and recording video or images, sensor apparatus in the nature of patient monitoring sensors reading a specific wavelength of light, portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device, medical products, namely, biofeedback sensors, electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; diagnostic apparatus for medical purposes, namely, blood testing apparatus, flow cytometers for medical diagnostic uses, sample preparation device for medical diagnostic uses; electromedical diagnostic instruments, namely, electromedical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA and RNA; apparatus for the treatment of cancer, namely, medical diagnostic imaging apparatus achieving images for treatment of cancer, medical imaging apparatus displaying cancer treatment information, electromagnetic diagnostic imaging apparatus incorporating recorded software for treatment of cancer, namely, for detecting the location of inflammation, abnormal or metamorphosed tissues, cells and cancer, location detection for biopsy, analysis of severity and possibility of inflammation, abnormal and metamorphosed tissues, cells and cancer, and estimating inflammation, abnormal tissues, cells and cancer; medical devices for treating cancer; medical measuring instruments for cancer diagnosis, namely, medical diagnostic apparatus for detecting cancer

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAIDOT Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameAIDOT Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameAIDOT Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, March 4, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 8, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 8, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 7, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 7, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, October 14, 2023EXPARTE APPEAL TERMINATED
Saturday, October 14, 2023EXPARTE APPEAL DISMISSED AS MOOT
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Sunday, August 20, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 2, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 2, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, July 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 12, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, July 12, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, July 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 30, 2023ASSIGNED TO LIE
Monday, March 6, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 6, 2023EX PARTE APPEAL-INSTITUTED
Monday, March 6, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, March 6, 2023EXPARTE APPEAL RECEIVED AT TTAB
Sunday, March 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, September 5, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 5, 2022FINAL REFUSAL E-MAILED
Monday, September 5, 2022FINAL REFUSAL WRITTEN
Tuesday, August 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 28, 2022REFUSAL PROCESSED BY IB
Wednesday, June 8, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 8, 2022REFUSAL PROCESSED BY MPU
Friday, May 6, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 5, 2022NON-FINAL ACTION WRITTEN
Friday, April 29, 2022ASSIGNED TO EXAMINER
Friday, September 17, 2021APPLICATION FILING RECEIPT MAILED
Monday, September 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB